메뉴 건너뛰기




Volumn 937, Issue , 2013, Pages 33-43

A validated assay for the simultaneous quantification of six tyrosine kinase inhibitors and two active metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry

Author keywords

LC MS MS; Metabolites; Tyrosine kinase inhibitors

Indexed keywords

CHROMATOGRAPHIC SYSTEMS; LC-MS/MS; LIQUID CHROMATOGRAPHY COUPLED WITH TANDEM MASS SPECTROMETRIES; LOWER LIMIT OF QUANTIFICATIONS; MULTIPLE-REACTION MONITORING MODES; SIMULTANEOUS DETERMINATIONS; TANDEM MASS SPECTROMETRY; TYROSINE KINASE INHIBITOR;

EID: 84883675913     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2013.08.013     Document Type: Article
Times cited : (84)

References (30)
  • 18
    • 84883708108 scopus 로고    scopus 로고
    • FDA, Guidance for Industry: Bioanalytical Method Validation.
    • FDA, 2001, Guidance for Industry: Bioanalytical Method Validation. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf.
    • (2001)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.